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Risk factors for pneumonia and influenza
hospitalizations in long-term care facility
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Patience Moyo1,2* , Andrew R. Zullo1,2,3,4, Kevin W. McConeghy1,4, Elliott Bosco1,2, Robertus van Aalst5,6,
Ayman Chit5,7 and Stefan Gravenstein1,2,4
Abstract
Background: Older adults who reside in long-term care facilities (LTCFs) are at particularly high risk for infection,
morbidity and mortality from pneumonia and influenza (P&I) compared to individuals of younger age and those
living outside institutional settings. The risk factors for P&I hospitalizations that are specific to LTCFs remain poorly
understood. Our objective was to evaluate the incidence of P&I hospitalization and associated person- and
facility-level factors among post-acute (short-stay) and long-term (long-stay) care residents residing in LTCFs
from 2013 to 2015.
Methods: In this retrospective cohort study, we used Medicare administrative claims linked to Minimum Data
Set and LTCF-level data to identify short-stay (< 100 days, index = admission date) and long-stay (100+ days,
index = day 100) residents who were followed from the index date until the first of hospitalization, LTCF
discharge, Medicare disenrollment, or death. We measured incidence rates (IRs) for P&I hospitalization per 100,
000 person-days, and estimated associations with baseline demographics, geriatric syndromes, clinical
characteristics, and medication use using Cox regression models.
Results: We analyzed data from 1,118,054 short-stay and 593,443 long-stay residents. The crude 30-day IRs
(95% CI) of hospitalizations with P&I in the principal position were 26.0 (25.4, 26.6) and 34.5 (33.6, 35.4)
among short- and long-stay residents, respectively. The variables associated with P&I varied between short
and long-stay residents, and common risk factors included: advanced age (85+ years), admission from an
acute hospital, select cardiovascular and respiratory conditions, impaired functional status, and receipt of
antibiotics or Beers criteria medications. Facility staffing and care quality measures were important risk factors
among long-stay residents but not in short-stay residents.
Conclusions: Short-stay residents had lower crude 30- and 90-day incidence rates of P&I hospitalizations than
long-stay LTCF residents. Differences in risk factors for P&I between short- and long-stay populations suggest
the importance of considering distinct profiles of post-acute and long-term care residents in infection
prevention and control strategies in LTCFs. These findings can help clinicians target interventions to
subgroups of LTCF residents at highest P&I risk.
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Background
Older adults (≥65 years of age) in long-term care facilities
(LTCFs) have a high risk of infection, hospitalization, and
death due to respiratory infections such as pneumonia and
influenza (P&I) [1–4]. These infections contribute to a sub-
stantial share of transfers to acute care hospitals [5], with
nearly one third of LTCF residents with pneumonia who
may require hospital admission [6]. Despite the significant
morbidity and economic burden imposed by P&I among
older adults, including in non-epidemic years [7–9], there
is scant contemporary research that comprehensively as-
sesses the risk factors for P&I resulting in hospitalization
among LTCF residents. Particular focus on P&I among
LTCF residents, whether short- or long-stay, is especially
warranted given that close living quarters and shared
caregivers found in an institutional environment can
increase the risk of exposure to infections and rate of
transmission [10].
Prior research focused on P&I hospitalization among
LTCF residents has also been limited in the number and
geographic distribution of facilities examined [5, 6, 11],
and most existing studies overlook the distinction between
short- and long-stay LTCF residents in their analyses [12–
14]. This is a relevant clinical and research consideration
given rising numbers of short-stay (i.e., post-acute care)
residents and distinct care goals and needs that distinguish
them from long-stay residents [15–17]. For example,
short-stay residents typically require rehabilitative nursing
immediately following hospitalization, whereas long-stay
residents predominantly receive custodial and chronic
care services [18].
This study builds on a previous research that found po-
tentially modifiable facility characteristics including
greater workforce hiring, more staffing hours, and higher
quality care practices were associated with lower incidence
rates for P&I hospitalization among LTCF residents [19].
To our knowledge, the Bosco et al. paper is the only one
on the topic to consider short- and long-stay LTCF resi-
dents separately in its analyses. While this prior study pro-
vides an understanding of the facility-level structural and
operational targets for improving infection control and
prevention in LTCFs, there remain knowledge gaps on the
individual-level risk factors and epidemiology of P&I
infections among older adults in LTCFs. Other studies
report variable respiratory infection incidence estimates
ranging from 1.1 to 85.2%, often without examining risk
factors. In the limited instances where examined,
individual-level risk factors for P&I including difficulty
with swallowing and lack of influenza vaccination have
been reported [6]. A study of LTCF residents in Japan
identified reduced activities of daily living status, swal-
lowing dysfunction, under-nourishment, ischemic heart
disease, and dementia as risk factors for incident pneu-
monia [20].
We investigated P&I events in a national sample of
Medicare beneficiaries residing in LTCFs from 2013 to
2015. Our objectives were to 1) determine the incidence
of P&I hospitalizations among short- and long-stay resi-
dents, and 2) assess individual and facility-level risk fac-
tors for P&I hospitalizations. We hypothesized that
resident-level demographics, medical conditions, geriat-
ric syndromes, and medication use, and facility-level
characteristics including staffing and care quality would
be associated with P&I.
Methods
Study design and data sources
This was a retrospective cohort study using Medicare en-
rollment, and Parts A and D claims linked to Minimum
Data Set (MDS) for 100% of LTCF residents enrolled in
fee-for-service Medicare during 2013–2015. Medicare Part
A data were used to identify hospitalizations involving
P&I, and Part D claims enabled the ascertainment of pre-
scribed medications. The MDS is a federally required clin-
ical assessment completed at admission and at least
quarterly thereafter among all residents in Medicare or
Medicaid certified nursing homes. MDS data provide a
comprehensive and standardized assessment of the func-
tional capabilities and health needs of LTCF residents [21,
22]. Specifically, MDS data include demographics, clinical
conditions, treatments, behaviors, physical function, and
cognitive status. We applied the residential history file al-
gorithm to track the timing and location of health services
utilization [23]. Facility-level variables were obtained from
Online Survey and Certification And Survey Provider En-
hanced Reports (OSCAR/CASPER) and LTCFocus data
collected for all Medicare- and Medicaid-certified LTCFs.
This study was approved by the Brown University Institu-
tional Review Board.
Study population
The study cohort was derived from a national source
population of Medicare beneficiaries residing in LTCFs
between January 1, 2013 and December 31, 2015. Eli-
gible residents were categorized as short-stay (total stay
< 100 days in the same LTCF), or long-stay (total stay
≥100 consecutive days with ≤10 days outside the facility).
Index dates were defined as the LTCF admission date
for short-stay residents and day 100 of a stay for long-
stay residents. We sampled the first LTCF stay, and
followed residents from their respective index dates until
hospitalization, discharge from the LTCF, disenrollment
from Medicare, death, or end of the study period, which-
ever occurred first. The cohort inclusion criteria were 1)
continuous enrollment in Medicare Parts A and D 6
months prior to index; 2) age at index ≥65 years; and 3)
≥1 MDS assessment within 100 days before the index
date for long-stay residents and upon entry to the facility
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for short-stay residents. We excluded residents with Medi-
care Advantage enrollment, who received hospice services,
or had missing data on any covariate used in analyses.
Resident-level risk factors
Risk factors were selected based on prior literature and our
clinical experience related to what factors could influence
P&I risk [6, 19, 24–26]. Resident characteristics were mea-
sured during the 6-month period prior to, or at, the index
date to ensure they were not influenced by the outcome.
We evaluated demographic, tobacco use, body mass index,
clinical (diagnoses and geriatric syndromes), medication
use and health service use variables as potential risk factors
for P&I hospitalizations. Demographic factors included
age, sex, race and ethnicity. Clinical diagnoses from MDS
included, e.g., cancer, atrial fibrillation, history of pneumo-
nia, diabetes mellitus, arthritis, Alzheimer’s disease,
asthma/chronic obstructive pulmonary disease (COPD)/
chronic lung disease. Among others [27], geriatric syn-
dromes included, e.g., cognitive function scale score [28],
Changes in Health, End-stage disease and Symptoms and
Signs (CHESS) scale score [29], and activities of daily living
(ADL) 28-point scale score [30]. The validated CHESS
score is primarily used as a risk adjustment tool to identify
LTCF residents with high health instability who are likely
to have adverse health outcomes, including death [31].
Medication use was defined as receiving ≥1 qualifying pre-
scription for antipsychotics, opioid analgesics [32], antibi-
otics, corticosteroids, or proton pump inhibitors as well as
for Beers criteria medications [33]. The Beers criteria iden-
tify specific medications and prescribing practices (e.g., ex-
cessive dose, prolonged treatment duration, harmful drug
combinations, and coexisting health conditions) with evi-
dence to suggest they should be avoided or used with cau-
tion by older adults due to unfavorable risk/benefit profiles
or questionable efficacy [34]. Examples of drug classes in
the Beers criteria are first generation antihistamines, barbi-
turates, benzodiazepines, proton-pump inhibitors, and es-
trogens. We measured the status of influenza vaccination
for the season of cohort entry based on index date and
up to date pneumococcal vaccination counting vaccina-
tions received within or outside the LTCF. We assessed
health service use as hospitalization and intensive care
unit (ICU) use.
Facility-level risk factors
As with resident-level factors, we considered facility fea-
tures based on prior literature and clinical experience,
including: 1) structural characteristics (urbanicity of fa-
cility location, total bed size, for-profit status); 2) staffing
hours (total nursing hours/resident/day); 3) staffing type;
and, 4) quality of care measures. Staffing type included
proportion of registered nurses (RNs), on-site presence
of a licensed independent practitioner (LIP) - either a
physician assistant (PA) or an advanced practice RN
(APRN), and speech language pathologist (SLP) on-staff
hours per 100 beds. Quality of care measures included
the percent of residents receiving antipsychotics, percent
of residents restrained, and percent of residents with a
pressure ulcer [19].
Pneumonia and influenza hospitalization
We identified P&I hospitalizations by the presence of
ICD-9 or ICD-10 diagnostic codes for pneumonia or
influenza-like-illness (480–488.XX, J09-J18) [35, 36].
The main analysis focused on P&I diagnoses in the prin-
cipal position on the claim. Secondarily, we analyzed
P&I identified from any diagnosis position.
Statistical analysis
We report the distribution of baseline characteristics of
the study cohort with means and percentages for the en-
tire cohort and among short- and long-stay residents.
The process of identifying the risk factors for P&I
hospitalization proceeded in three steps. First, we
grouped the variables into domains as follows: demo-
graphics, admission characteristics (location resident was
admitted from, LTCF admission is new), cardiovascular
conditions (atrial fibrillation, coronary artery disease,
heart failure, hypertension, cerebrovascular accident), re-
spiratory conditions (asthma/COPD/chronic lung dis-
ease, respiratory failure, pneumonia), other medical
conditions (cancer, Parkinson’s disease, depression, dia-
betes mellitus, arthritis), cognition (Alzheimer’s and non-
Alzheimer’s dementia, cognitive function scale), physical
function (ADLs, urinary/bowel continence), overall
health stability (CHESS scale score, Charlson comorbid-
ity score, prognosis, prior hospitalization and/or ICU
stay), breathing (shortness of breath, ventilator/respir-
ator use), eating (tube feeding, swallowing disorders),
medication use, vaccinations, and facility characteristics.
Second, we examined intercorrelations of variables
within domains using a Pearson’s correlation coefficient
matrix. None of the bivariate correlations reached a level
(r > 0.8) indicating severe multicollinearity. We included
state fixed effects to help account for potential state-
level differences in LTCFs' propensity to hospitalize resi-
dents and code for P&I on hospital claims.
Finally, all variables from the domains identified in the
first step were entered into a Cox proportional hazards
model specified to account for clustering of residents within
facilities using the Huber-White sandwich estimator. A sta-
bility analysis assessed an alternative Fine and Gray com-
peting risk regression modeling approach with death as a
competing outcome. Considering the large sample size, an
alpha = 0.01 significance level was used to guide identifica-
tion of potential P&I risk factors in the final model.
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Data preparation and analyses were conducted using
SAS version 9.4 (SAS Institute, Inc., Cary, NC) and Stata
version 15 (StataCorp, College Station, TX). We secured
administrative permission to access Medicare data
through a Data Use Agreement with the Centers for
Medicare and Medicaid Services (CMS). Informed con-





The cohort comprised 1,711,497 individuals residing in
15,740 unique Medicare-certified LTCFs. Of these,
65.3% (n = 1,118,054) were short-stay and 34.7% (n =
593,443) long-stay residents (Additional file 1: Fig. S1).
Compared to short-stay residents, long-stay residents
were older (mean age: 82.9 vs. 80.8 years), and had more
female (71.3% vs. 68.8%) and Black residents (11.1% vs.
7.3%) (Table 1). Generally, the prevalence of severe geri-
atric syndromes including cognitive impairments, de-
pendency for ADL, and Charlson comorbidities was
greater among long-stay residents than short-stay resi-
dents. Receipt of any medication in the Beers criteria
was common in both short (60.1%) and long-stay
(71.8%) residents. More than half received influenza
(56% short-stay, 66% long-stay) and pneumococcal (67%
short-stay, 72% long-stay) vaccinations. At the facility
level, three-quarters of all residents were in facilities in
urban areas, and nearly two-thirds (63.1%) were in facil-
ities with at least 100 total beds.
The overall prevalence of P&I hospitalizations was
3.0% for diagnoses in the principal position (short-stay
0.5%; long-stay 2.5%) and 6.6% considering any diagnosis
position (short-stay 3.5%; long-stay 3.1%). At 30 days
post-index, short-stay residents had 6345 hospitaliza-
tions with a principal diagnosis of P&I, and 21,942 in
any diagnosis position (Table 2). Over the same period,
long-stay residents had 5410 and 12,819 hospitalizations
with P&I diagnoses in the principal and any position;
respectively.
Incidence rate
For P&I hospitalizations in the principal position, the
crude incidence rate (IR) and 95% confidence intervals
among short-stay residents was 26.0 (25.4–26.6) per 100,
000 person-days at 30 days and remained unchanged at
90 days post-index (Table 2). Among long-stay residents,
the crude IR was 34.5 (33.6–35.4) at 30 days and 28.6
(28.1–29.1) at 90 days post-index. Capturing P&I in any
diagnosis position yielded IRs approximately 2 to 3 times
more events than using diagnoses only in the principal
position. P&I incidence rates varied across age, sex, race
and ethnicity (Fig. 1a-c).
Multivariable results of cox proportional hazards models
Risk factors among long-stay residents
Among long-stay residents, the risk factors for P&I
hospitalization included increasing age, admission
from an acute care hospital, LTCF re-entry, presence
of cardiovascular (atrial fibrillation, heart failure) and
respiratory conditions (pneumonia, asthma/COPD, re-
spiratory failure) in MDS assessments (Table 3). Ex-
tensive limitations in ADLs, overall health instability,
and increased comorbidity burden were associated
with the incidence of P&I hospitalization. Shortness
of breath (HR = 1.34, 99% CI, 1.28–1.39), tube feeding
(HR = 1.30, 99% CI, 1.20–1.41), and ventilator or res-
pirator use (HR = 1.34, 99% CI, 1.03–1.75) were also
identified as important risk factors. Those with any
use of medications on the Beers criteria, prescriptions
for antibiotics and corticosteroids, receipt of influenza
or pneumococcal vaccinations, and prior ICU use had
an increased rate of P&I.
P&I hospitalizations were less common among resi-
dents who were female, Black, diagnosed with certain
conditions such as dementia, and prescribed antipsy-
chotics than among residents without these
characteristics.
Facility-level characteristics associated with higher
risk of P&I hospitalization among long-stay residents
were for-profit status and poor care quality measures
such as greater use of antipsychotics or restraints.
Residents in LTCFs with more RNs, and having LIPs
and SLPs on site had a decreased rate of P&I com-
pared with those at facilities without such staffing.
LTCFs located in urban settings (HR = 0.77, 99% CI,
0.74–0.79) and with higher bed capacity (HR = 0.89,
99% CI, 0.84–0.94 for > 200 beds versus < 200 beds)
were associated with lower P&I hospitalizations.
Risk factors among short-stay residents
Results among the short-stay population were largely
consistent with the direction of findings in the long-
stay population although the magnitude of the associ-
ations tended to differ. Receipt of influenza and
pneumococcal vaccination suggested a 1% decreased
rate of P&I hospitalization among short-stay residents;
however, this association did not meet statistical sig-
nificance. While facility structural characteristics,
staffing type, and care quality measures were import-
ant predictors among long-stay residents; these vari-
ables were not associated with P&I among short-stay
residents.
Secondary analyses
Considering P&I diagnoses in any position, rather
than those only in the primary position, indicated
variation in how the variables were related to P&I
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Table 1 Baseline characteristics of long-term care facility residents, 2013–2015
Characteristics, n (%) All
N = 1,711,497




Length of follow-up, days, mean ± SD 112 ± 200 29 ± 20 269 ± 278
Age at index date, years, mean ± SD 81.6 ± 8.2 80.8 ± 8.1 82.9 ± 8.3
65–74 394,331 (23.0) 281,767 (25.2) 112,564 (19.0)
75–84 639,132 (37.3) 434,977 (38.9) 204,155 (34.4)
85+ 678,034 (39.6) 401,310 (35.9) 276,724 (46.6)
Female sex 1,191,557 (69.6) 768,633 (68.8) 422,924 (71.3)
Race/ethnicity
Non-Hispanic White 1,420,689 (83.0) 943,096 (84.4) 477,593 (80.5)
Non-Hispanic Black 147,231 (8.6) 81,401 (7.3) 65,831 (11.1)
Hispanic 62,070 (3.6) 36,682 (3.3) 25,388 (4.3)
Location resident was admitted from
Community or home 124,588 (7.3) 37,208 (3.3) 87,380 (14.7)
Another LTCF or swing beda 61,435 (3.6) 19,777 (1.8) 41,658 (7.0)
Hospital 1,486,083 (86.8) 1,044,083 (93.4) 442,000 (74.5)
LTCF admission is new 1,441,102 (84.2) 1,019,035 (91.1) 422,067 (71.1)
Body mass index, kg/m2
< 18.5, underweight 117,888 (6.9) 76,489 (6.8) 41,392 (7.0)
18.5–24.9, normal 656,364 (38.4) 424,751 (38.0) 231,590 (39.0)
25–29.9, overweight 480,408 (28.0) 313,886 (28.1) 166,511 (28.1)
≥ 30, obese 456,890 (26.7) 302,928 (27.1) 153,950 (25.9)
Current tobacco use 47,959 (2.8) 24,811 (2.2) 23,148 (3.9)
Clinical Characteristics from MDS
Cancer 141,791 (8.3) 108,447 (9.7) 33,344 (5.6)
Atrial fibrillation or other dysrhythmias 441,467 (25.8) 307,971 (27.8) 133,496 (22.5)
Coronary artery disease 452,352 (26.4) 304,647 (27.3) 147,705 (24.9)
Heart failure 385,850 (22.5) 243,464 (21.9) 142,386 (24.0)
Hypertension 1,352,541 (79.0) 877,554 (78.5) 474,987 (80.0)
History of pneumonia 125,660 (7.3) 104,590 (9.4) 21,070 (3.6)
Diabetes mellitus 554,424 (32.4) 347,402 (31.1) 207,022 (34.9)
Arthritis 517,064 (30.2) 339,561 (30.4) 177,503 (29.9)
Alzheimer’s disease 107,700 (6.3) 35,684 (3.2) 72,016 (12.1)
Cerebrovascular accident, transient ischemic attack, or stroke 197,397 (11.5) 104,438 (9.3) 92,959 (15.7)
Non-Alzheimer’s dementia 406,597 (23.8) 165,369 (14.8) 241,228 (40.7)
Depression 595,844 (34.8) 314,369 (28.1) 281,475 (47.4)
Asthma, chronic obstructive pulmonary disease, chronic lung disease 410,086 (24.0) 269,238 (24.1) 140,848 (23.7)
Respiratory failure 44,460 (2.6) 33,858 (3.0) 10,602 (1.8)
Parkinson’s disease 74,036 (4.3) 36,366 (3.3) 37,670 (6.4)
Geriatric Syndromes
Cognitive Function Scale score
Intact/mild cognitive impairment (0–1) 1,001,934 (58.5) 778,937 (52.1) 222,997 (37.6)
Moderate cognitive impairment (2, 3) 680,284 (39.8) 325,810 (29.1) 354,474 (59.7)
Severe cognitive impairment (4–6) 29,274 (1.7) 13,307 (1.2) 15,972 (2.7)
Activities of Daily Living 28-point Scale score
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Table 1 Baseline characteristics of long-term care facility residents, 2013–2015 (Continued)
Characteristics, n (%) All
N = 1,711,497




None to limited assistance required (0–14) 795,028 (46.5) 582,547 (46.5) 212,481 (38.5)
Extensive assistance required (15–19) 620,211 (36.2) 385,371 (34.5) 234,840 (39.5)
Extensive dependency (≥20) 296,258 (17.3) 150,136 (13.4) 146,122 (24.6)
CHESS Scale score, overall health stability
No instability (0) 990,561 (57.9) 650,661 (58.2) 339,900 (57.3)
Minimal instability (1, 2) 701,695 (41.0) 456,279 (40.8) 245,416 (41.4)
Moderate to very high instability (3+) 19,241 (1.1) 11,114 (1.0) 8127 (1.4)
Charlson comorbidity score (MDS)
0 155,594 (9.1) 117,051 (10.5) 38,543 (6.5)
1–2 719,649 (42.1) 484,120 (43.3) 235,529 (39.7)
≥ 3 836,254 (48.9) 516,883 (46.2) 319,371 (53.8)
Urinary incontinence: frequent/always 529,756 (31.0) 238,989 (21.4) 290,767 (49.0)
Bowel incontinence: frequent/always 403,981 (23.6) 190,054 (17.0) 403,981 (23.6)
Shortness of breath 258,935 (15.1) 172,789 (15.5) 86,146 (14.5)
Swallowing disorder 65,162 (3.8) 46,058 (4.1) 19,104 (3.2)
Tube feeding 33,988 (2.0) 17,140 (1.5) 16,848 (2.8)
Ventilator or respirator use 1741 (0.1) 678 (0.1) 1063 (0.2)
Prognosis: less than 6 months to live 7145 (0.4) 5274 (0.5) 1871 (0.3)
Died during study period 2013–2015 812,036 (47.4) 459,028 (41.1) 353,008 (59.5)
Medication Use 6 months before index
Beers criteria medication,b any use 1,098,173 (64.2) 672,349 (60.1) 425,824 (71.8)
Antipsychotics, any use 96,289 (5.6) 39,659 (3.6) 56,630 (9.5)
Opioid analgesics, any use 127,139 (7.4) 99,251 (8.9) 27,888 (4.7)
Antibiotics, any usec 704,363 (41.2) 461,537 (41.3) 242,826 (40.9)
Corticosteroids, any use 99,079 (5.8) 72,409 (6.5) 26,670 (4.5)
Proton pump inhibitors, any use 328,345 (19.2) 229,345 (20.5) 99,000 (16.7)
Influenza vaccine received for season of cohort entry 1,021,615 (59.7) 628,356 (56.2) 393,259 (66.3)
Pneumococcal vaccination up to date 1,177,063 (68.8) 749,307 (67.0) 427,756 (72.1)
Health Service Use 6 months before index
Any hospitalization use 1,388,076 (81.1) 1,037,211 (92.8) 350,865 (59.1)
Any ICU use 454,699 (26.6) 340,691 (30.5) 114,008 (19.2)
Facility Structural Characteristics
Urban location 1,298,856 (75.9) 886,434 (79.3) 412,422 (69.5)
Total bed size
< 100 630,730 (36.9) 415,999 (37.2) 214,731 (36.2)
100–200 882,091 (51.5) 570,832 (51.1) 311,259 (51.5)
> 200 198,676 (11.6) 131,223 (11.7) 67,453 (11.4)
For-profit facility 1,159,613 (67.8) 746,395 (66.8) 413,218 (69.6)
Facility Staffing Type and Hours
Ratio of RN to RN + LPN, mean ± SD 0.4 ± 0.2 0.4 ± 0.2 0.3 ± 0.2
SLP on-staff, hours / 100 Beds, mean ± SD 0.5 ± 1.6 0.6 ± 1.6 0.4 ± 1.4
LIP on-site 773,827 (45.2) 515,034 (46.1) 258,793 (43.6)
Total nursing hours/resident/day, mean ± SD 4.9 ± 9.4 5.3 ± 10.5 4.3 ± 6.8
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hospitalization (Additional file 1: Table S1). For ex-
ample, having received influenza vaccination (HR =
0.97, 99% CI, 0.94–0.99) was protective against P&I
hospitalization among short-stay residents when P&I
diagnoses in any position were considered in the out-
come. The competing risk analyses yielded interpreta-
tions substantively similar to the main results;
however, select medical conditions (e.g., cancer, atrial
fibrillation) had inconsistent findings (Additional file
1: Table S2).
Discussion
This study examined risk factors for P&I hospitalization
among short- and long-stay residents of LTCFs. The in-
cidence of P&I hospitalizations varied between these
cohorts. Despite several shared risk factors, there also
were differences in the direction and magnitude of the
associations across short and long-stay residents de-
pending on whether P&I diagnoses in the principal ver-
sus any diagnosis position were considered, and based
on accounting for death as a competing risk.
In the main analysis focused on hospitalizations
with P&I in the principal position, resident-level vari-
ables that were consistently associated with increased
risk among both short and long-stay residents were
older age (85+), admission from an acute hospital,
LTCF reentry, atrial fibrillation/dysrhythmias, asthma/
COPD/chronic lung disease, extensive ADL limita-
tions, shortness of breath, Beers criteria medication
use, and history of antibiotic prescriptions. Among fa-
cility characteristics, urban location was associated
with lower rates of P&I hospitalizations for both short
and long-stay residents. We observed that being over-
weight or obese was associated with reduced risk for
P&I hospitalization among short-stay residents. This
may reflect the obesity paradox [37]; however, the
underlying mechanism for this likely non-linear rela-
tionship remains unclear and has been reported for
pneumonia in reduction of mortality rather than
hospitalization [38].
The variations we observed in the direction and/or
magnitude of the hazard ratios depending on resident
type (short vs. long-stay) and P&I diagnosis position
(principal vs. any) call attention to the need for nu-
anced strategies for preventing and controlling P&I
considering these patient profiles. In particular, poten-
tially modifiable risk factors at both individual (e.g.,
medication use, chronic disease management of
Table 1 Baseline characteristics of long-term care facility residents, 2013–2015 (Continued)
Characteristics, n (%) All
N = 1,711,497





Antipsychotic use, % of residents, mean ± SD 18.9 ± 11.2 17.2 ± 10.3 22.1 ± 12.2
Restraint use, % of residents, mean ± SD 2.0 ± 4.5 1.8 ± 4.3 2.4 ± 4.8
Pressure ulcers, % of residents, mean ± SD 6.5 ± 4.7 6.7 ± 4.8 6.2 ± 4.3
Abbreviations: LTCF long-term care facility, MDS Minimum Data Set, CHESS Changes in Health, End-stage disease and Symptoms and Signs, RN Registered Nurse,
LPN Licensed Practical Nurse, SLP Speech Language Pathologist, LIP Licensed Independent Practitioner
a Swing beds are LTCF beds that can serve both short-stay and long-stay residents depending on need
b The Beers criteria is a specific list of potentially inappropriate medications that are not recommended for use among older adults in most circumstances or
under specific situations
c Antibiotics recommended in the Infectious Diseases Society of America/American Thoracic Society consensus guidelines on the management of community-
acquired pneumonia in adults
Table 2 Crude incidence rates of pneumonia and influenza-related hospitalizations among short- and long-stay residents in U.S.
long-term care facilities, 2013–2015
Days since index date Short-stay residents (N = 1,118,054) Long-stay residents (N = 593,443)
30 90 30 90 180 365
Total person-days observed 24,395,364 32,290,058 15,668,663 41,150,984 70,681,373 111,720,666
Primary diagnosis position on the hospital claim
Number of hospitalizations 6345 8412 5410 11,777 18,202 26,891
Crude IR per 100,000 (95% CI) 26.0 (25.4–26.6) 26.1 (25.5–26.6) 34.5 (33.6–35.4) 28.6 (28.1–29.1) 25.8 (29.4–30.2) 24.1 (23.8–24.4)
Any diagnosis position on the hospital claim
Number of hospitalizations 21,942 28,943 12,819 28,046 43,220 63,560
Crude IR per 100,000 (95% CI) 89.9 (88.8–91.1) 89.6 (88.6–90.7) 81.8 (80.4–83.2) 68.2 (67.3–69.0) 61.1 (60.6–61.7) 56.9 (56.4–57.3)
IR incidence rate, CI confidence interval
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Fig. 1 (See legend on next page.)
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cardiorespiratory conditions) and facility levels (e.g.,
staffing, care quality) represent important opportun-
ities to reduce the incidence of P&I-related hospitali-
zations. We acknowledge the unexpected results
whereby select conditions (e.g., Parkinson’s disease,
dementia, arthritis) and individual-level medication
use (e.g., antipsychotic, proton pump inhibitors) ap-
peared to confer protective effects among short- and/
or long-stay residents. This represents an opportunity
for future research into these associations.
The positive relationship between vaccinations and
P&I hospitalizations among long-stay residents could
reflect a tendency for those at greatest risk of P&I in-
fection or most vulnerable to hospitalization to re-
ceive vaccines. If so, vaccine use in LTCF residents
would be subject to confounding by indication. Re-
search that assesses provider and patient decision-
making regarding the offer and acceptance of vaccin-
ation may shed additional light on this. Nonetheless,
annual influenza vaccination is recommended and has
been found cost-effective in preventing and control-
ling infection and other negative sequelae [39]. There
is uncertainty about the effectiveness of the pneumo-
coccal vaccine at preventing pneumonia in the elderly
[40–42]; however, limited evidence suggests the vac-
cine may decrease in-hospital death, length of hospital
stay and the need for ICU admission among those
with community-acquired pneumonia [43, 44]. As
such, there is benefit in recommending pneumococcal
vaccination and broadly increasing vaccination cover-
age in LTCFs [45]. Furthermore, improving pneumo-
coccal vaccination rates and preventing pneumonia is
a priority for CMS. For example, the agency promul-
gated immunization standards as part of the LTCF
conditions of participation [46], and initiated public
reporting of pneumococcal vaccination rates [47].
Additionally, 30-day mortality and hospital readmis-
sion measures for pneumonia are part of the hospital
quality initiative [48]. Our results identifying individ-
uals at highest risk for P&I can be used to target pre-
vention interventions to those residents who are most
likely to benefit, and thus may help providers comply
with CMS quality initiatives.
This study has limitations. First, our definition of P&I
hospitalization relies on inpatient claims alone and mis-
ses infections that are not evaluated by diagnostic test-
ing or those that did not result in hospitalization.
Furthermore, P&I may be underestimated due to cod-
ing practices that arise when providers confer higher
priority to other comorbidities over P&I for billing pur-
poses, or if P&I go unrecognized due to the severity of
co-occurring clinical conditions. Nonetheless, our sen-
sitivity analysis capturing P&I diagnoses in all positions
on the claim help address this limitation. Second, infor-
mation on risk factors was ascertained potentially at
least 6 months before the onset of the outcome in long-
stay residents. Therefore, resident characteristics at the
time of P&I may not have fully aligned with those
present at baseline. However, our approach maintained
the temporal relationship between risk factors and the
outcome. Third, relative to long-stay residents, short-
stay residents more frequently had missing information
on MDS-derived variables (and thus more likely to be
excluded from analysis) as they may not have had as
many MDS assessments. By excluding residents with
missing information, we avoided making untenable as-
sumptions that would be required to conduct multiple
imputation and related approaches to handle missing
data. Fourth, direct observation is longer for long-stay
than short stay residents, as the risk exposure time is
truncated upon short stay residents’ discharge to the
community. This potentially underestimates the risk of
P&I hospitalization among short-stay residents though
our focus was on events occurring within LTCFs. Fur-
thermore, to the extent that LTCFs have different ten-
dencies to transfer short versus long stay residents to
the hospital, the observed IRs for P&I could be differ-
entially underestimated. Finally, the study population
comprised Medicare beneficiaries residing in LTCFs
and were ≥ 65 years of age; therefore, our findings may
not extend to other settings (e.g., community), younger
LTCF residents, or beneficiaries of other insurance
sources.
Conclusions
In an older adult LTCF population, IRs of P&I hospital-
izations were greater among long-stay than short-stay
residents. There were variations in the risk factors, and
magnitude of associations, that predicted P&I hospitali-
zations between short- and long-stay residents when
using principal versus any P&I diagnosis position and
differing modeling approaches. Nonetheless, we identi-
fied several risk factors in common in these two popu-
lations including advanced age, admission from an
(See figure on previous page.)
Fig. 1 a Crude incidence rate (per 100,000 person-days) of hospitalizations with pneumonia and influenza as primary diagnosis within 30 days of
index by age group. b Crude incidence rate (per 100,000 person-days) of hospitalizations with pneumonia and influenza as primary diagnosis
within 30 days of index by sex. c Crude incidence rate (per 100,000 person-days) of hospitalizations with pneumonia and influenza as primary
diagnosis within 30 days of index by race and ethnicity
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Table 3 Results of multivariable analyses to identify factors associated with hospitalizations for P&I as the primary diagnosis among





Age group (ref = 65–74)
75–84 1.08 (1.00, 1.17) 1.11 (1.06, 1.15)
85+ 1.16 (1.06, 1.27) 1.23 (1.18, 1.28)
Sex (ref = male) 0.84 (0.79, 0.89) 0.83 (0.80, 0.85)
Race and ethnicity
Non-Hispanic White (ref = non-White) 1.00 (0.87, 1.15) 1.03 (0.97, 1.11)
Non-Hispanic Black (ref = non-Black) 0.86 (0.72, 1.03) 0.89 (0.82, 0.97)
Hispanic (ref = non-Hispanic) 1.02 (0.82, 1.27) 1.05 (0.95, 1.15)
Location resident is admitted from (ref = hospital)
Community or home 0.81 (0.67, 0.98) 0.79 (0.76, 0.83)
Another LTCF or swing bedd 0.99 (0.77, 1.26) 0.92 (0.87, 0.97)
Other location 0.78 (0.60, 1.02) 0.86 (0.81, 0.93)
Type of admission is reentry (ref = new) 6.50 (6.09, 6.95) 1.43 (1.39, 1.47)
Body mass index, kg/m2 (ref = 18.5–24.9, normal)
< 18.5, underweight 1.14 (1.03, 1.25) 1.05 (0.99, 1.11)
25–29.9, overweight 0.88 (0.82, 0.95) 0.98 (0.95, 1.01)
≥ 30, obese 0.74 (0.68, 0.81) 0.98 (0.95, 1.02)
Current tobacco use (ref = no tobacco use) 0.87 (0.72, 1.06) 1.01 (0.95, 1.07)
Clinical Characteristics from MDS
Cancer 1.20 (1.10, 1.32) 1.00 (0.94, 1.07)
Atrial fibrillation or other dysrhythmias 1.13 (1.06, 1.21) 1.05 (1.01, 1.08)
Coronary artery disease 1.00 (0.94, 1.07) 1.01 (0.98, 1.04)
Heart failure 1.00 (0.92, 1.08) 1.13 (1.08, 1.18)
Hypertension 1.02 (0.95, 1.10) 0.99 (0.96, 1.02)
History of pneumonia 3.60 (3.36, 3.85) 1.38 (1.29, 1.46)
Diabetes mellitus 0.98 (0.91, 1.05) 1.02 (0.99, 1.06)
Arthritis 0.92 (0.85, 0.98) 0.95 (0.92, 0.98)
Alzheimer’s disease 0.79 (0.67, 0.94) 0.89 (0.86, 0.93)
Cerebrovascular accident, transient ischemic attack, or stroke 0.80 (0.72, 0.89) 0.89 (0.86, 0.93)
Non-Alzheimer’s dementia 0.91 (0.84, 0.99) 0.87 (0.84, 0.89)
Depression 0.98 (0.92, 1.05) 1.07 (1.05, 1.10)
Asthma, chronic obstructive pulmonary disease, chronic lung disease 1.48 (1.38, 1.58) 1.56 (1.51, 1.61)
Respiratory failure 1.11 (0.99, 1.24) 1.13 (1.03, 1.24)
Parkinson’s disease 0.82 (0.69, 0.97) 0.95 (0.90, 1.00)
Geriatric Syndromes
Cognitive Function Scale score (ref = no/mild impairment)
Moderate cognitive impairment (2, 3) 0.95 (0.89, 1.02) 0.90 (0.87, 0.92)
Severe cognitive impairment (4–6) 1.21 (1.01, 1.45) 0.92 (0.84, 1.01)
Activities of Daily Living 28-point Scale score (ref = None to limited assistance required)
Extensive assistance required (15–19) 1.56 (1.45, 1.68) 1.08 (1.05, 1.11)
Extensive dependency (≥20) 1.91 (1.74, 2.08) 1.08 (1.04, 1.12)
CHESS Scale score, overall health stability (ref = stable)
Minimal instability (1, 2) 1.21 (1.12, 1.33) 1.09 (1.04, 1.14)
Moderate to very high instability (3+) 1.04 (0.84, 1.28) 1.17 (1.04, 1.32)
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Charlson comorbidity score (MDS) (ref = 0)
1–2 1.10 (0.96, 1.26) 1.04 (0.98, 1.10)
≥ 3 1.15 (0.99, 1.34) 1.12 (1.04, 1.19)
Urinary or bowel incontinence (ref = none) 1.11 (1.04, 1.18) 0.99 (0.96, 1.02)
Shortness of breath 2.26 (2.09, 2.43) 1.34 (1.28, 1.39)
Swallowing disorder 0.91 (0.80, 1.03) 0.96 (0.89, 1.04)
Tube feeding 0.90 (0.76, 1.07) 1.30 (1.20, 1.41)
Ventilator or respirator use while in facility 1.48 (0.82, 2.67) 1.34 (1.03, 1.75)
Prognosis: less than 6 months to live 0.88 (0.61, 1.25) 0.80 (0.62, 1.04)
Medication Use 6 months before index
Beers Criteria medication,e any use 1.09 (1.03, 1.16) 1.09 (1.06, 1.13)
Antipsychotics, any use 0.86 (0.74, 1.01) 0.81 (0.77, 0.86)
Opioid analgesics, any use 1.11 (1.01, 1.23) 0.97 (0.91, 1.03)
Antibiotics,f any use 1.15 (1.08, 1.22) 1.30 (1.27, 1.34)
Corticosteroids, any use 1.10 (1.00, 1.22) 1.10 (1.04, 1.17)
Proton pump inhibitors, any use 1.04 (0.97, 1.12) 0.87 (0.84, 0.91)
Influenza vaccine received for season of cohort entry 0.99 (0.92, 1.05) 1.09 (1.06, 1.13)
Pneumococcal vaccination up to date 0.99 (0.92, 1.06) 1.06 (1.03, 1.10)
Health Service Use 6 months before index
Any Hospitalizations 1.04 (0.92, 1.18) 0.91 (0.88, 0.94)
Any ICU use 1.06 (0.99, 1.13) 1.06 (1.02, 1.11)
Facility Structural Characteristics
Urban location (ref = non-urban) 0.87 (0.80, 0.93) 0.77 (0.74, 0.79)
Total bed size (ref = < 100)
100–200 0.94 (0.88, 1.01) 0.91 (0.88, 0.94)
> 200 0.93 (0.82, 1.06) 0.89 (0.84, 0.94)
For profit facility (ref = not for profit) 1.01 (0.90, 1.08) 1.05 (1.02, 1.08)
Facility Staffing Type and Hours
Ratio of RN to RN + LPN (fifth vs. first quintile) 0.91 (0.81, 1.02) 0.90 (0.85, 0.95)
SLP on-staff hours / 100 Beds (fifth vs. first quintile) 1.02 (0.94, 1.11) 0.99 (0.98, 1.00)
LIP on-site (ref = none) 1.02 (0.96, 1.08) 0.93 (0.90, 0.95)
Total nursing hours/resident/day (fifth vs. first quintile) 0.87 (0.78, 0.97) 0.99 (0.95, 1.04)
Facility Care Quality
Antipsychotic use, % of residents (fifth vs. first quintile) 1.00 (0.90, 1.10) 1.07 (1.02, 1.11)
Restraint use, % of residents (fifth vs. first quintile) 1.02 (0.94, 1.10) 1.07 (1.04, 1.11)
Pressure ulcers, % of residents (fifth vs. first quintile) 0.96 (0.87, 1.05) 1.01 (0.96, 1.05)
Values in boldface indicate statistically significant associations at the 0.01 level
Abbreviations: LTCF long-term care facility, MDS Minimum Data Set, CHESS Changes in Health, End-stage disease and Symptoms and Signs, RN
Registered Nurse, LPN Licensed Practical Nurse, SLP Speech Language Pathologist, LIP Licensed Independent Practitioner
a N = 1,080,816 after 37,238 (3.3%) were excluded from regression due to missing data on facility-level variables
b N = 571,694 after 21,749 (3.7%) were excluded from regression due to missing data on facility-level variables
c We used robust Huber-White standard errors to account for clustering of residents within LTCFs
d Swing beds are LTCF beds that can serve both short-stay and long-stay residents depending on need
e The Beers criteria is a specific list of potentially inappropriate medications that are not recommended for use among older adults in most
circumstances or under specific situations
f Antibiotics recommended in the Infectious Diseases Society of America/American Thoracic Society consensus guidelines on the management of
community-acquired pneumonia in adults
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acute hospital, presence of cardiovascular and respira-
tory conditions, impaired functional status, receipt of
antibiotics, and prescriptions meeting the Beers criteria
for potentially inappropriate use in older adults. Inter-
ventions aimed at improving infection prevention and
control in LTCFs should be differentiated depending
on resident type as those primarily receiving limited
duration post-acute care may require different strat-
egies than longer term residents.
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